Alkem Laboratories Limited has informed the Exchange about Schedule of meet

Alkem Laboratories has informed the stock exchange about the schedule of an upcoming meeting. The filing is a routine regulatory disclosure under SEBI's listing requirements, where companies notify the exchange in advance about planned investor conferences, analyst calls, or one-on-one meetings. No specific details about the agenda, participants, or date of the meeting are mentioned in the headline. These meetings are typically used by companies to engage with institutional investors and analysts and may include updates on business performance and strategy.